Skip to main content

. 1976;69(Suppl 2):47–48. doi: 10.1177/00359157760690S212

Hypolipidaemic action of gemfibrozil in adult nephrotics.

A Eisalo, V Manninen, M Mälkönen, B Kuhlbäck

PMCID: PMC1864013 PMID: 798197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BAXTER J. H., GOODMAN H. C., ALLEN J. C. Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis. J Clin Invest. 1961 Mar;40:490–498. doi: 10.1172/JCI104276. [DOI] [PMC free article] [PubMed] [Google Scholar]
Berlyne G. M., Mallick N. P. Ischaemic heart-disease as a complication of nephrotic syndrome. Lancet. 1969 Aug 23;2(7617):399–400. doi: 10.1016/s0140-6736(69)90110-x. [DOI] [PubMed] [Google Scholar]
Bridgman J. F., Rosen S. M., Thorp J. M. Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. Lancet. 1972 Sep 9;2(7776):506–509. doi: 10.1016/s0140-6736(72)91905-8. [DOI] [PubMed] [Google Scholar]
Brons M., Christensen N. C., Horder M. Hyperlipoproteinemia in patients with chronic renal failure. Acta Med Scand. 1972 Jul-Aug;192(1-2):119–123. doi: 10.1111/j.0954-6820.1972.tb04787.x. [DOI] [PubMed] [Google Scholar]
Chopra J. S., Mallick N. P. Hyperlipoproteinaemias in nephrotic syndrome. Lancet. 1971 Feb 13;1(7694):317–320. doi: 10.1016/s0140-6736(71)91044-0. [DOI] [PubMed] [Google Scholar]
Hyman L. R., Wong P. W., Grossman A. Plasma lipoprotein lipase in children with idiopathic nephrotic syndrome. Pediatrics. 1969 Dec;44(6):1021–1024. [PubMed] [Google Scholar]
Letter: Serum-H.D.L. in atherosclerotic heart-disease. Lancet. 1976 May 8;1(7967):1014–1014. [PubMed] [Google Scholar]
MARSH J. B., DRABKIN D. L. Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia. Metabolism. 1960 Oct;9:946–955. [PubMed] [Google Scholar]
Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
Newmark S. R., Anderson C. F., Donadio J. V., Ellefson R. D. Lipoprotein profiles in adult nephrotics. Mayo Clin Proc. 1975 Jul;50(7):359–364. [PubMed] [Google Scholar]
Pierides A. M., Alvarez-Ude F., Kerr D. N. Clofibrate-induced muscle damage in patients with chronic renal failure. Lancet. 1975 Dec 27;2(7948):1279–1282. doi: 10.1016/s0140-6736(75)90613-3. [DOI] [PubMed] [Google Scholar]
Yamada M., Matsuda I. Lipoprotein lipase in clinical and experimental nephrosis. Clin Chim Acta. 1970 Dec;30(3):787–794. doi: 10.1016/0009-8981(70)90276-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES